Article Menu
Need Help?
No Article Versions Notes Found
Cite
Bouganim, N.; Mamo, A.; Wasserman, D.W.; Batist, G.; Metrakos, P.; Chaudhury, P.; Hassanain, M.; Kavan, P. Bevacizumab-Based Therapy for Colorectal Cancer: Experience from a Large Canadian Cohort at the Jewish General Hospital between 2004 and 2009. Curr. Oncol. 2013, 20, 247-251. https://doi.org/10.3747/co.20.1370
Bouganim N, Mamo A, Wasserman DW, Batist G, Metrakos P, Chaudhury P, Hassanain M, Kavan P. Bevacizumab-Based Therapy for Colorectal Cancer: Experience from a Large Canadian Cohort at the Jewish General Hospital between 2004 and 2009. Current Oncology. 2013; 20(5):247-251. https://doi.org/10.3747/co.20.1370
Chicago/Turabian StyleBouganim, N., A. Mamo, D.W. Wasserman, G. Batist, P. Metrakos, P. Chaudhury, M. Hassanain, and P. Kavan. 2013. "Bevacizumab-Based Therapy for Colorectal Cancer: Experience from a Large Canadian Cohort at the Jewish General Hospital between 2004 and 2009" Current Oncology 20, no. 5: 247-251. https://doi.org/10.3747/co.20.1370
APA StyleBouganim, N., Mamo, A., Wasserman, D. W., Batist, G., Metrakos, P., Chaudhury, P., Hassanain, M., & Kavan, P. (2013). Bevacizumab-Based Therapy for Colorectal Cancer: Experience from a Large Canadian Cohort at the Jewish General Hospital between 2004 and 2009. Current Oncology, 20(5), 247-251. https://doi.org/10.3747/co.20.1370
